How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,372 results for

E/M Examination Criteria

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Evidence Map - Art Therapy

K, Erdogan C, Mutlu H, Demir M, Coskun S. A comparative study of art therapy in cancer patients receiving chemotherapy and improvement in quality of life by watercolor painting. Complementary therapies in medicine. 2017;30(1873-6963 (Electronic)):67-72. 13. Lefevre C, Ledoux M, Filbet M. Art therapy among palliative cancer patients: Aesthetic dimensions and impacts on symptoms. Palliative & supportive care. 2016;14(1478-9523 (Electronic)):376-380. 14. Rhondali W, Lasserre E, Filbet M. Art (...) , Wirth JH, Lai J, Shott S. Relieving symptoms in cancer: innovative use of art therapy. Journal of pain and symptom management. 2006;31(0885- 3924 (Print)):162-169. 20. Geue K, Richter R, Buttstadt M, Brahler E, Singer S. An art therapy intervention for cancer patients in the ambulant aftercare - results from a non-randomised controlled study. European journal of cancer care. 2013;22(1365-2354 (Electronic)):345-352. 21. Singer S, Gotze H, Buttstadt M, et al. A non-randomised trial of an art therapy

2019 Veterans Affairs Evidence-based Synthesis Program Reports

182. Emergency Drought Relief Package: Health and Resilience Services

citations using a specific set of criteria. In total, we assessed 250 full-text articles for eligibility and we noted information from 144 studies, with 130 providing information on Question 1 (74 studies were original research — citations are provided in Appendix 2) and 23 providing some information on Question 2 (14 studies provided more detailed information for evaluation outcome purposes — see Appendix 3), and 5 studies provided information for NHRMC evidence grading). In addition, to answer (...) living in drought-affected communities? 10 DROUGHT, HEALTH AND RESILIENCE SERVICES | SAX INSTITUTE Methods Peer review literature This Evidence Check followed the standard Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA), namely: 1) identification of literature; 2) screening questions; and 3) eligibility using inclusion criteria. We conducted a search of the literature from January 1998 to December 2018 in electronic databases PsycINFO, PubMed, Web of Science and Google

2019 Sax Institute Evidence Check

183. Addressing unwarranted variation in healthcare

E, Mears S, Hinchcliff R, Heslop D. Addressing unwarranted variation in healthcare: an Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for Cancer Institute NSW, 2019 Disclaimer: This Evidence Check Review was produced using the Evidence Check methodology in response to specific questions from the commissioning agency. It is not necessarily a comprehensive review of all literature relating to the topic area. It was current at the time of production (...) , synonyms and subject headings were developed for the major concepts of clinical variation, quality improvement and (facilitated) feedback. Two electronic databases (Medline and PubMed) were searched from January 2000 to August 2018, in addition to hand-searching of relevant journals, reference lists and grey literature. Results were merged using reference-management software (Covidence) and duplicates removed. The inclusion criteria were independently applied to potentially relevant articles by three

2019 Sax Institute Evidence Check

184. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

. Further details on the characteristics and outcomes of these studies can be found in the Data TABLE 3. Revised International Staging System Stage ISS Criteria I ISS stage I (b 2 -M, 3.5 mg/L and serum albumin $ 3.5 g/dL) and normal LDH, no abnormal FISH II Neither stage 1 or stage III III b 2 -M. 5.5 mg/L and elevated serum LDH, or abnormal FISH: presence of t(4;14), t(14;20), or 17p deletion NOTE. Adapted with permission from Palumbo et al. 5 Abbreviations: FISH, ?uorescence in situ hybridization (...) 15 ;DavidH.Vesole,MD,PhD 16,17 ;IrwinWalker,MBBS 18 ; Alexander Whitley, MD, PhD 19 ; Tanya M. Wildes,MD 20 ; Sandy W. Wong,MD 21 ;and Tom Martin,MD 21 abstract PURPOSE To provide evidence-based recommendations on the treatment of multiple myeloma to practicing physicians and others. METHODS ASCO and Cancer Care Ontario convened an Expert Panel of medical oncology, surgery, radiation oncology,andadvocacyexpertstoconductaliteraturesearch,whichincludedsystematicreviews,meta-analyses, randomized

2019 Cancer Care Ontario

185. Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

://www.cancercare.on.ca/ or contact the PEBC office at: Phone: 905-527-4322 ext. 42822 Fax: 905-526-6775 E-mail: ccopgi@mcmaster.ca EBS 2-4- Version 3 Section 1: Guideline Recommendations Page 5 REFERENCES 1. Simunovic M, Stewart L, Zwaal C, Johnston M; Diagnostic Imaging Guidelines Panel. Cross- sectional imaging in colorectal cancer [monograph on the Internet]. 2006 Apr 12 [cited 2008 Feb 22]. Available from: http://www.cancercare.on.ca/pdf/pebcdicrc.pdf. 2. O'Connell MJ, Colangelo LH, Beart RW, Petrelli NJ (...) , Controlled Trial (GRECCAR-6). J Clin Oncol. 2016 Nov 1;34(31):3773-3780. 4. Lefevre JH, Mineur L, Cachanado M, Rullier E, Rouanet P, De Chaisemartin C, The French Research Group of Rectal Cancer Surgery (GRECCAR). Does a longer waiting period after neoadjuvant radiochemotherapy improve the oncological prognosis of rectal cancer? Three-year follow-up results of the GRECCAR-6 randomized multicenter trial. ASCO 2019 Jan. Meeting Abstract. 5. Hong YS, Kim SY, Lee JS, Nam BH, Kim JE, Kim KP, et al. Long-term

2019 Cancer Care Ontario

186. Economic Analyses of Policies to Reduce Cervical Cancer

FOUND We identified a total of 25 relevant documents by searching five databases (Health Systems Evidence, Cochrane Library, Health Evidence, EconLit and PubMed), and the search strategy for these databases are detailed in Box 2. We applied the following inclusion criteria (as outlined by the requestor): 1) time period (2002 to present); 2) jurisdictional focus on Canada and other high- income countries with a similar socio-economic context (e.g., Group of Seven countries, Northwest Europe (...) practices (compared to screening alone), finding €8,408 euros/QALY gained.(18) One primary study examined cost-effectiveness by comparing the quadrivalent and the bivalent vaccines (cohort of 100,000 girls aged 12 years), and the cost-utility ratio for the bivalent vaccine was $31,000/QALY gained and $21,000/QALY gained for the quadrivalent vaccine.(19) Another primary study used the published data from the previous study to re-evaluate the cost-effectiveness model.(20) The author found that the model

2019 McMaster Health Forum

187. New Direct-acting Antiviral for Hepatitis C (Epclusa?

following bleeding after taking Xofluza, it is reasonable to consider that hemorrhage was an adverse reaction to the agent and was the Editorial C M ED HECK Translated from the Editorial in Med Check(in Japanese) May 09 ; 9 (5) cause of death. Denying the causality between Xofluza and death is a usual practice and deliberate decision by the MHLW. Xofluza was designated as an agent for "preferential treatment system in examination" at the trial stage, and the examination period was greatly shortened (...) with ribavirin In practice In patients with chronic hepatitis C or HCV compensated cirrhosis who failed previous treatment with existing DAAs, SOF/VEL combination taken for 24 weeks in combination with ribavirin is recommended for all types of HCVs. F u r t h e r m o r e , i n p a t i e n t s w i t h a d v a n c e d , decompensated cirrhosis, SOF/VEL combination taken for 12 weeks is recommended for all types of HCVs. In many patients with diabetes who are on hypoglycemic agents, as viral load decreases

2019 Med Check - The Informed Prescriber

188. Critical Assessment of Diabetes Guidelines

following bleeding after taking Xofluza, it is reasonable to consider that hemorrhage was an adverse reaction to the agent and was the Editorial C M ED HECK Translated from the Editorial in Med Check(in Japanese) May 09 ; 9 (5) cause of death. Denying the causality between Xofluza and death is a usual practice and deliberate decision by the MHLW. Xofluza was designated as an agent for "preferential treatment system in examination" at the trial stage, and the examination period was greatly shortened (...) with ribavirin In practice In patients with chronic hepatitis C or HCV compensated cirrhosis who failed previous treatment with existing DAAs, SOF/VEL combination taken for 24 weeks in combination with ribavirin is recommended for all types of HCVs. F u r t h e r m o r e , i n p a t i e n t s w i t h a d v a n c e d , decompensated cirrhosis, SOF/VEL combination taken for 12 weeks is recommended for all types of HCVs. In many patients with diabetes who are on hypoglycemic agents, as viral load decreases

2019 Med Check - The Informed Prescriber

189. Using Multi-source Feedback and Other Practice Assessments for Quality Assurance in Nursing

the research evidence with 10 key informant interviews. • Relatively few findings emerged from the literature that explicitly described the effectiveness of multi- source feedback at improving professionals’ clinical practice, however it was found that effectiveness tended to vary based on the competencies being assessed. • Similarly, few studies were found that examined the use of multi-source feedback among nurses, however findings from its use for physicians indicate it is a valid, reliable and feasible (...) considerations for its use with a nursing workforce? We identified six systematic reviews and four primary studies that related to the first question. The six systematic reviews all examined the use of multi-source feedback among physicians, while the four primary studies examined its use for nurses and those training to become nurses. In addition, interviews with 10 key informants complemented Box 2: Identification, selection and synthesis of research evidence We identified research evidence (systematic

2019 McMaster Health Forum

190. Autologous hematopoietic cell transplantation for autoimmune diseases

the combined search results, 1990 articles were assessed by title and abstract for possible inclusion in the evidence summary. Of these, 1759 articles were rejected at the title level and the remaining (n=231) were assessed at the level of full text. Of these, 226 were excluded at full text resulting in six RCTs meeting inclusion criteria. See PRISMA diagram in Appendix 3. Two of the RCTs evaluated MS [8,9], three examined SSc [10-12], and one examined IBD (hereby referred to as Crohn’s disease [CD]/IBD (...) the efficacy and safety of aHCT in SSc searching the literatures from 1966 to January 2018. Four studies met inclusion criteria (3 RCTs [11,12,15] and 1 retrospective cohort study [16]). The comparison group was monthly cyclophosphamide (CYC) in all of the three RCTs. Table 1-1 reports the characteristics of the six included RCTs. Of the two studies examining MS, one study was a phase II [8] and the other was a phase III trial [9]. Both MS studies (MIST and ASTIMS) were multi-centred [8,9]. Mean age

2019 Cancer Care Ontario

191. Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

. Models of care for cancer survivorship [Internet]. Toronto: Cancer Care Ontario; 2017 March [cited 2018 Jan 3]. Available at: https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/246 3 Sussman J, McBride M, Sisler J, Kim G, Game L, Ozokwelu E, et al. Assessment of re-entry support mechanisms during survivorship care transitions. Poster session presented at: Health Quality Transformation Presents: Quality Matters 2016; 2016 Oct 20; Toronto. 4 Mittmann N, Beglaryan H, Liu N, Seung SJ (...) , Rahman F, Gilbert J, et al. Evaluating the impact of survivorship models on health system resources and costs. J Clin Onc. 2018 Mar;36(7_suppl):1-1. DOI: 10.1200/JCO.2018.36.7_suppl.1 5 Brouwers MC, Vukmirovic M, Tomasone JR, Grunfeld E, Urquhart R, O’Brien M, et al. Documenting coordination of cancer care between primary care providers and oncology specialists in Canada. Can Fam Physician. 2016 Oct;62(10):e616-e625. 6 Trebble TM, Hansi N, Hydes T, Smith MA, Baker M. Process mapping the patient

2019 Cancer Care Ontario

192. Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario Guideline 5-3ORG Version 2 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario J. Irish, J. Kim, J. Waldron, A. Wei, E. Winquist, J. Yoo, A. Boasie, M. Brouwers, E. Meertens, S. McNair, C. Walker-Dilks and the Expert Panel on Organizational Guidance for the Care of Patients with Head (...) and Neck Cancer in Ontario This document is an update of the organizational guidance portion of the 2009 version of the guideline (Evidence-Based Series 5-3 The Management of Head and Neck Cancer in Ontario). Report Date: April 25, 2019 For information about this document, please contact Dr. Jon Irish, the lead author, through the PEBC via: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: ccopgi@mcmaster.ca For information about the PEBC and the most current version of all reports, please visit

2019 Cancer Care Ontario

193. Delivering novel therapies in the 21st century

small nanoneedles (upwards of 40 per cell) to probe inside the cell and deliver biomolecules in vivo, for example to muscles to regenerate blood vessels. Stevens’ group has also pioneered a variety of methods to elucidate the cell-material interface and study what happens when drug delivery vehicles enter cells. Raman microscopy and quantitative volumetric Raman imaging, a novel technique, are used to examine cell chemistry changes and response to small molecules without labelling the cells. Single (...) , and significantly improved therapeutic efficacy. Of particular note was the radiological response of tumour types, such as colorectal, which are not known to respond to doxorubicin treatment when delivered by conventional means. Image: Professor Constantin Coussios, University of Oxford. 1. Lyon P.C., Gray M.D., Mannaris C., Folkes L.K., Stratford M., Campo L., Chung D.Y.F., Scott S., Anderson M., Goldin R., Carlisle R., Wu F., M.R. Middleton, F.V. Gleeson, C.C. Coussios (2018) Safety and feasibility

2019 Academy of Medical Sciences

194. Effects of trauma-informed approaches in schools: A systematic review

review sought to examine the effects trauma‐informed schools on trauma symptoms/mental health, academic performance, behavior, and socioemotional functioning. Although we conducted a comprehensive search to find studies testing trauma‐informed approaches in schools, no studies met the inclusion criteria. 1.3 What are the main findings of this review? No studies met criteria for this review, indicating that there is a lack of evidence of trauma‐informed approaches in schools. 1.4 What do the findings (...) interventions for adolescents (e.g., Black, Woodworth, Tremblay, & Carpenter, ; Cary & McMillen, ) and those that examine school‐based interventions for specific trauma‐related disorders, such as PTSD (e.g., Rolfsnes & Idsoe, ); however, these reviews are examining effects of trauma‐specific interventions rather than trauma‐informed approaches. By virtue of these studies' primary research questions and inclusion criteria, the scope of these reviews were not designed to examine effects of a trauma‐informed

Full Text available with Trip Pro

2019 Campbell Collaboration

195. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders

they did not fulfil the eligibility criteria. 6.2 Overall completeness and applicability of evidence The review included only two trials and the results found no clear evidence of the benefits of CBT for ATS‐use disorders. Both of the included studies examined relatively uncommon approaches such as a one‐session brief therapy and a web‐based therapy. Therefore, the evidence obtained in this review could not be applicable across the wide range of treatment modalities and settings. 6.3 Quality (...) of Psychology, Mejiro University, Tokyo, Japan Faculty of International Relations, University of Shizuoka, Shizuoka, Japan Corresponding Author E-mail address: Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan Correspondence Rintaro Mori, Department of Health Policy National Center for Child Health and Development 2‐10‐1 Okura Setagaya‐ku 157‐0074 Tokyo Tokyo Japan. Email: Criminology, Law and Society, George Mason University, Fairfax, Virginia, USA Department

Full Text available with Trip Pro

2019 Campbell Collaboration

196. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

baseline to end of intervention exceeded minimal clinically important differences for the PCL-M, CAPS-IV and BDI-II. However, because these studies lacked usual care or wait-list control groups and were not specifically designed to examine differential effectiveness by TBI status we concluded that evidence is insufficient regarding treatment effectiveness among Veterans and service members with mTBI (Executive Summary Table 4). · A small, pre-post, uncontrolled, proof of concept study of hyperbaric (...) , Spoont M, Taylor B, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. VA ESP Project #09-009; 2019. Available at: https

2019 Veterans Affairs Evidence-based Synthesis Program Reports

197. Digital platforms as effective health promotion tools

, PsycINFO, Scopus and ProQuest databases to identify studies that conducted user testing of digital platforms with parents (Q2) and evaluated the effectiveness of digital platforms targeting parents (Q3). We included studies if they were published in English, published from 2008 (Q2) or from 2013 (Q3) and conducted in Australia or other specified countries of interest. The quality of included studies was evaluated against the NHMRC evidence grade. Thirty studies met the criteria for inclusion (...) enabling personalisation and interactivity that were desired in user testing. However, evaluating the website in its current form to determine its effectiveness would inform whether additional improvements were required. There is a gap in the market for evidence-based apps to support parental lunch-box provision, which is worth examining as a potential opportunity. Conclusion The Evidence Check demonstrated that digital health promotion tools targeting parents can be effective for improving dietary

2019 Sax Institute Evidence Check

198. Out-of-pocket costs associated with HIV in publicly funded high-income health care settings

insure specific populations (2). Provinces and territories decide on the eligibility criteria for public drug insurance and the level of subsidy, and select the products to be listed on their drug formularies (2). Consequently, Canadians with identical prescriptions may pay substantially different amounts and may rely on private insurance, public funders, out-of-pocket payments or a combination of these to pay for their medications (2). The aim of this review is to highlight out-of-pocket costs (...) and Nova Scotia (2). Ontario, Quebec, Saskatchewan, and Newfoundland and Labrador have multiple programs with eligibility criteria varying according to age, income or drug costs (2). The programs also differ in other ways. For example, although British Columbia, Alberta, New Brunswick and Prince Edward Island provide antiretrovirals at no cost to their residents, these provinces do not provide universal coverage of prescriptions not related to HIV (2). Coordination of benefits with private insurers

2019 Ontario HIV Treatment Network

199. Guidelines on Supraventricular Tachycardia (for the management of patients with)

Paediatric and Congenital Cardiology (AEPC) Josep Brugada Chairperson Spain Corresponding authors: Josep Brugada, Cardiology Department, Hospital Clinic, and Pediatric Arrhythmia Unit, Hospital Sant Joan de Déu, University of Barcelona, Spain. Tel: +34 3460 902 2351, Fax: +34 3493 227 1777, Email: jbrugada@clinic.cat. Search for other works by this author on: , Demosthenes G Katritsis Chairperson Greece Demosthenes G. Katritsis, Department of Cardiology, Hygeia Hospital, E. Stavrou 4, 15123 Athens (...) of supraventricular tachycardia 9 Table 6 Differential diagnosis of narrow and wide QRS tachycardias 9 Table 7 Initial evaluation of the patient with supraventricular tachycardia 10 Table 8 Possible responses of narrow QRS tachycardia to vagal manoeuvres and adenosine 13 Table 9 Summary of key electrocardiographic criteria that suggest ventricular tachycardia rather than supraventricular tachycardia in wide complex tachycardia 14 Table 10 Causes of physiological sinus tachycardia 19 Table 11 Average success

Full Text available with Trip Pro

2019 European Society of Cardiology

200. Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD

, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen, Heikki V Huikuri, Isabelle Johansson, Peter Jüni, Maddalena Lettino, Nikolaus Marx, Linda G Mellbin, Carl J Östgren, Bianca Rocca, Marco Roffi, Naveed Sattar, Petar M Seferović, Miguel Sousa-Uva, Paul Valensi, David C Wheeler, ESC Scientific Document Group, 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular (...) works by this author on: , Victor Aboyans France Search for other works by this author on: , Clifford J Bailey United Kingdom Search for other works by this author on: , Antonio Ceriello Italy Search for other works by this author on: , Victoria Delgado Netherlands Search for other works by this author on: , Massimo Federici Italy Search for other works by this author on: , Gerasimos Filippatos Greece Search for other works by this author on: , Diederick E Grobbee Netherlands Search for other works

Full Text available with Trip Pro

2019 European Society of Cardiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>